Atlas Trials

Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant

Clinical trial NCT03297528 · UNKNOWN

Trial details

NCT number
NCT03297528
Sponsor
Peking University People's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Donor Lymphocyte InfusionAllogeneic Hematopoietic Stem Cell TransplantationAcute LeukemiaMinimal Residual DiseaseGraft-versus-host DiseaseRelapse
Start date
2017-03-01
Primary completion
2020-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.